A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
Cheng-Zuo Xiao(Sun Yat-sen University), Rong Guo(Sun Yat-sen University), Yong‐Fa Zhang(Sun Yat-sen University), Jia-hong Wang(Sun Yat-sen University), Shu-Hong Li(Sun Yat-sen University), Wei Wei(Zhujiang Hospital), Ming Shi(Yanshan University)
Cited by 11
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160